6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Breast cancer is one of the most common cancers and leading causes of death in the women worldwide. The evidence shows efficacy of apatinib against breast cancer. Accordingly, the present study was conducted to investigate the effect of apatinib on apoptosis, cell cycle, and Mitogen‑Activated Protein Kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways in the breast cancer MDA-MB-231 cell line.

          Related collections

          Author and article information

          Journal
          Breast Cancer
          Breast cancer (Tokyo, Japan)
          Springer Science and Business Media LLC
          1880-4233
          1340-6868
          Jul 2020
          : 27
          : 4
          Affiliations
          [1 ] Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
          [2 ] Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
          [3 ] Department of Medical Laboratory Sciences, Faculty of Medicine, Islamic Azad University (IAU), Sari, Iran.
          [4 ] Clinical Laboratory Medicine Department, Rofeydeh Hospital, University of Social Welfare and Rehabilition Sciences (USWR), Tehran, Iran.
          [5 ] Department of Biochemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
          [6 ] Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
          [7 ] Bioinformatics and Computational Biology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
          [8 ] Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
          [9 ] Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
          [10 ] Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
          [11 ] Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Rashidi@tbzmed.ac.ir.
          [12 ] Stem Cell And Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran. nourimd@yahoo.com.
          Article
          10.1007/s12282-020-01055-6
          10.1007/s12282-020-01055-6
          32026267
          4720fd6f-df96-4048-82d3-430aef70abce
          History

          MAPK,Breast cancer,Nf-κb,Apatinib
          MAPK, Breast cancer, Nf-κb, Apatinib

          Comments

          Comment on this article